APOE ε4 positivity was found to be significantly associated with disease status, with higher percentages of APOE ε4 positivity observed in the AD group (67.5%) compared to the MCI group (50.2%) and the CN group (29%) (p < 0.001). The gene discussed is APOE; the disease is Alzheimer disease.